Preoperative skeletal muscle density is associated with postoperative mortality in patients with cardiovascular disease.


Journal

Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399

Informations de publication

Date de publication:
01 04 2020
Historique:
received: 20 07 2019
revised: 26 11 2019
accepted: 02 12 2019
pubmed: 31 12 2019
medline: 17 12 2020
entrez: 31 12 2019
Statut: ppublish

Résumé

Although skeletal muscle density (SMD) is useful for predicting mortality, the cut-off in an acute clinical setting is unclear, especially in patients with cardiovascular disease (CVD). This study was performed to determine the preoperative SMD cut-off using the psoas muscle and to investigate the effect on postoperative outcomes, including sarcopaenia, in CVD patients. Preoperative psoas SMD was measured by abdominal computed tomography in CVD patients. Postoperative sarcopaenia was defined according to the criteria of the Asia Working Group for Sarcopaenia. The Youden index was used to test the predictive accuracy of survival models. The prognostic capability was evaluated using multivariable survival and receiver operating characteristic curve analyses. Continuous data were available for 1068 patients (mean age 65.5 years; 63.6% male). A total of 105 (9.8%) deaths occurred during the 1.99-year median follow-up period (interquartile range 0.71-4.15). The psoas SMD cut-off estimated by the Youden index was 45 Hounsfield units with high sensitivity and moderate specificity for all-cause mortality and was consistent in various stratified analyses. After adjusting for the existing prognostic model, EuroSCORE II, preoperative and postoperative physical status, psoas SMD cut-off was predicted for mortality (hazard ratio 2.42, 95% confidence interval 1.32-4.45). The psoas SMD cut-off was also significantly associated with postoperative sarcopaenia and provided additional prognostic information to EuroSCORE II on receiver operating characteristic curve analysis (area under the curve 0.627 vs 0.678, P = 0.011). Reduced psoas SMD was associated with postoperative mortality and added information prognostic for mortality to the existing prognostic model in CVD patients.

Identifiants

pubmed: 31886866
pii: 5690331
doi: 10.1093/icvts/ivz307
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

515-522

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Masashi Yamashita (M)

Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.

Kentaro Kamiya (K)

Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.
Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.

Atsuhiko Matsunaga (A)

Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.
Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.

Tadashi Kitamura (T)

Department of Cardiovascular Surgery, Kitasato University School of Medicine, Sagamihara, Japan.

Nobuaki Hamazaki (N)

Department of Rehabilitation, Kitasato University Hospital, Sagamihara, Japan.

Ryota Matsuzawa (R)

Department of Physical Therapy, School of Rehabilitation, Hyogo University of Health Sciences, Hyogo, Japan.

Kohei Nozaki (K)

Department of Rehabilitation, Kitasato University Hospital, Sagamihara, Japan.

Takafumi Ichikawa (T)

Department of Rehabilitation, Kitasato University Hospital, Sagamihara, Japan.

Takeshi Nakamura (T)

Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.

Shohei Yamamoto (S)

Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.

Hidenori Kariya (H)

Department of Rehabilitation, Kitasato University Hospital, Sagamihara, Japan.

Emi Maekawa (E)

Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.

Kentaro Meguro (K)

Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.

Misao Ogura (M)

Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.

Minako Yamaoka-Tojo (M)

Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.

Junya Ako (J)

Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.

Kagami Miyaji (K)

Department of Cardiovascular Surgery, Kitasato University School of Medicine, Sagamihara, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH